Advanced in Osteosarcoma

Yuhui Shen

Shanghai, CN 
Advanced in Osteosarcoma
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Yuhui Shen practices in Shanghai, China. Shen is rated as an Advanced expert by MediFind in the treatment of Osteosarcoma. Their top areas of expertise are Osteosarcoma, Adult Soft Tissue Sarcoma, Bone Tumor, and Necrosis.

Their clinical research consists of co-authoring 32 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 20 articles and participated in 2 clinical trials in the study of Osteosarcoma.

Locations

Shanghai, 200025, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II Study of Gemcitabine-docetaxel Chemotherapy With Anti-angiogenic Therapy for Pulmonary Resectable Metastases of Osteosarcoma
A Phase II Study of Gemcitabine-docetaxel Chemotherapy With Anti-angiogenic Therapy for Pulmonary Resectable Metastases of Osteosarcoma
Enrollment Status: Active_not_recruiting
Publish Date: November 01, 2023
Intervention Type: Drug
Study Drugs: Apatinib, GD regimen
Study Phase: Phase 2
A Pilot Study of Circulating Exosome RNA as Diagnostic and Prognostic Markers in Lung Metastases of Primary High-Grade Osteosarcoma
A Pilot Study of Circulating Exosome RNA as Diagnostic and Prognostic Markers in Lung Metastases of Primary High-Grade Osteosarcoma
Enrollment Status: Active_not_recruiting
Publish Date: October 03, 2023
Intervention Type: Other
View 1 Less Clinical Trial

32 Total Publications

The Outcome of Discontinuing Tyrosine Kinase Inhibitors in Advanced Sarcoma Following a Favorable Tumor Response to Antiangiogenics Therapy.
The Outcome of Discontinuing Tyrosine Kinase Inhibitors in Advanced Sarcoma Following a Favorable Tumor Response to Antiangiogenics Therapy.
Journal: Journal of clinical medicine
Published: November 24, 2022

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Shen's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile